Company: SVREW
Filing Date: 2025-03-21
Form Type: 20-F
Source: 0001013762-25-001028
Chunk: 26

Company: SaverOne 2014 Ltd.
Filing Date: 2025-03-21
Form: 20-F
Item: Item 3
Chunk 26
---
 Trademark Office, or USPTO, or made a misleading statement, during prosecution. The validity
of U. S. patents may also be challenged in post-grant proceedings before the USPTO. The outcome following legal assertions of invalidity
and unenforceability is unpredictable.

Derivation
proceedings initiated by third parties or brought by us may be necessary to determine the priority of inventions and/or their scope with
respect to our patent or patent applications or those of our licensors. An unfavorable outcome could require us to cease using the related
technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does
not offer us a license on commercially reasonable terms. Our defense of litigation or interference proceedings may fail and, even if
successful, may result in substantial costs and distract our management and other employees. In addition, the uncertainties associated
with litigation could have a material adverse effect on our ability to raise the funds necessary to continue our research programs, license
necessary technology from third parties, or enter into development partnerships that would help us bring our new products to market.

Furthermore,
because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some
of our confidential information could be compromised by disclosure during this type of litigation. There could also be public announcements
of the results of hearings, motions, or other interim proceedings or developments. If securities analysts or investors perceive these
results to be negative, it could have a material adverse effect on the price of our ADSs or ordinary shares.

In
Israel, three of our patent applications have been allowed and subsequently opposed by a third-party. Further to the evidence submitted
by the opponent, we are now requested to submit evidence by March 20, 2025, and the proceedings are still ongoing. It is difficult to
assess at this time the likelihood of success in the opposition. Opposition proceedings in Israel tend to be lengthy and very procedural.

We
may be subject to claims challenging the inventorship of our intellectual property.

We
may be subject to claims that former employees, collaborators or other third parties have an interest in, or right to compensation, with
respect to our current patent and patent applications, future patents or other intellectual property as an inventor or co-inventor. For
example, we may have inventorship disputes arise from conflicting obligations of consultants or others who are involved in developing
our products. Litigation may be necessary to defend against these and other claims